Clinical Trials Logo

Clinical Trial Summary

Evaluation whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of reduced hospital readmissions, improved health related quality of life and health status. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Chronic Disease
  • Pulmonary Disease, Chronic Obstructive
  • Pulmonary Disease, Chronic Obstructive (COPD)

NCT number NCT01580072
Study type Interventional
Source Landeskrankenanstalten-Betriebsgesellschaft
Contact
Status Completed
Phase N/A
Start date February 2010
Completion date February 2014

See also
  Status Clinical Trial Phase
Completed NCT02551224 - Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) N/A
Recruiting NCT03269721 - COPD-Related Physiology and the Brain
Active, not recruiting NCT01976117 - E-nose Utility in the Diagnosis of Bacterial Infection in COPD N/A
Active, not recruiting NCT05915182 - Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Trixeo Aerosphereâ„¢ in Routine Care Settings in Greece
Completed NCT02596009 - Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices Phase 4